Evidence map›Paper›PMID 27748751›Full record

ArticleNature chemical biology2016

Structural and conformational determinants of macrocycle cell permeability.

Björn Over, Pär Matsson, Christian Tyrchan, Per Artursson, Bradley C Doak, Michael A Foley, Constanze Hilgendorf, Stephen E Johnston, Maurice D Lee, Richard J Lewis and 6 more

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Nature chemical biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 81 papers.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed.

  1. Article
  2. MinimalRSC chemical biology · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Björn OverCardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca R&D Gothenburg, Mölndal, Sweden.ORCID 0000-0002-9185-5420
Pär MatssonDepartment of Pharmacy, Uppsala University, Uppsala, Sweden.ORCID 0000-0002-9094-2581
Christian TyrchanRespiratory, Inflammation and Autoimmunity Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca R&D Gothenburg, Mölndal, Sweden.
Per ArturssonDepartment of Pharmacy, Uppsala University, Uppsala, Sweden.
Bradley C DoakDepartment of Chemistry, Uppsala University, Uppsala, Sweden.
Michael A FoleyCenter for the Science of Therapeutics, Broad Institute, Cambridge, Massachusetts, USA.
Constanze HilgendorfDrug Safety and Metabolism, Safety &ADME Translational Sciences, AstraZeneca R&D Gothenburg, Mölndal, Sweden.
Stephen E JohnstonCenter for the Science of Therapeutics, Broad Institute, Cambridge, Massachusetts, USA.
Maurice D LeeCenter for the Science of Therapeutics, Broad Institute, Cambridge, Massachusetts, USA.
Richard J LewisRespiratory, Inflammation and Autoimmunity Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca R&D Gothenburg, Mölndal, Sweden.
Patrick McCarrenCenter for the Science of Therapeutics, Broad Institute, Cambridge, Massachusetts, USA.
Giovanni MuncipintoCenter for the Science of Therapeutics, Broad Institute, Cambridge, Massachusetts, USA.
Ulf NorinderSwedish Toxicology Sciences Research Center, Södertälje, Sweden.
Matthew W D PerryRespiratory, Inflammation and Autoimmunity Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca R&D Gothenburg, Mölndal, Sweden.
Jeremy R DuvallCenter for the Science of Therapeutics, Broad Institute, Cambridge, Massachusetts, USA.
Jan KihlbergDepartment of Chemistry, Uppsala University, Uppsala, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Macrocycles are of increasing interest as chemical probes and drugs for intractable targets like protein-protein interactions, but the determinants of their cell permeability and oral absorption are poorly understood. To enable rational design of cell-permeable macrocycles, we generated an extensive data set under consistent experimental conditions for more than 200 non-peptidic, de novo-designed macrocycles from the Broad Institute's diversity-oriented screening collection. This revealed how specific functional groups, substituents and molecular properties impact cell permeability. Analysis of energy-minimized structures for stereo- and regioisomeric sets provided fundamental insight into how dynamic, intramolecular interactions in the 3D conformations of macrocycles may be linked to physicochemical properties and permeability. Combined use of quantitative structure-permeability modeling and the procedure for conformational analysis now, for the first time, provides chemists with a rational approach to design cell-permeable non-peptidic macrocycles with potential for oral absorption.

Indexed as

Caco-2 CellsHumansMacrocyclic CompoundsMolecular StructurePermeabilityStereoisomerismStructure-Activity RelationshipMacrocyclic Compounds

Identifiers

PMID27748751

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.